Connor, Clark & Lunn Investment Management (CC&L)’s Amicus Therapeutics FOLD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $15.9M | Buy |
|
|||||
|
2025
Q2 | $10.5M | Buy |
|
|||||
|
2025
Q1 | $6.42M | Buy |
|
|||||
|
2024
Q4 | $2.85M | Buy |
|
|||||
|
2024
Q3 | $2.38M | Buy |
|
|||||
|
2024
Q2 | $1.46M | Buy |
|
|||||
|
2024
Q1 | – | Sell |
|
|||||
|
2023
Q4 | $1.57M | Buy |
|
|||||
|
2023
Q3 | $785K | Buy |
|
|||||
|
2023
Q2 | $665K | Buy |
|
|||||
|
2023
Q1 | $386K | Buy |
|
|||||
|
2022
Q3 | – | Sell |
|
|||||
|
2022
Q2 | $1.19M | Buy |
|
|||||
|
2021
Q1 | – | Sell |
|
|||||
|
2020
Q4 | $2.49M | Buy |
|
|||||
|
2018
Q2 | – | Sell |
|
|||||
|
2018
Q1 | $173K | Sell |
|
|||||
|
2017
Q4 | $2.25M | Sell |
|
|||||
|
2017
Q3 | $6.43M | Buy |
|
|||||
|
2017
Q2 | $219K | Buy |
|
|||||
|
2016
Q1 | – | Sell |
|
|||||
|
2015
Q4 | $1.26M | Sell |
|
|||||
|
2015
Q3 | $5.36M | Sell |
|
|||||
|
2015
Q2 | $9.79M | Sell |
|
|||||
|
2015
Q1 | $9.1M | Buy |
|
|||||
|
2014
Q4 | $4.38M | Buy |
|
|||||
|
2014
Q3 | $813K | Buy |
|
|||||
|
2014
Q2 | – | Sell |
|
|||||
|
2014
Q1 | $33K | Sell |
|
|||||
|
2013
Q4 | $69K | Buy |
|
|||||
|
2013
Q3 | $46K | Buy |
|